Rights and permissions
About this article
Cite this article
Infant Hep B vaccination favoured in cost-effectiveness terms. Pharmacoecon. Outcomes News 73, 9 (1996). https://doi.org/10.1007/BF03270191
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03270191